リウマチ科治療法の世界市場:疾病種類別(慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他)、薬種類別(非ステロイド性抗炎症薬(NSAID)、鎮痛剤、疾患修飾性抗リウマチ薬(DMARD)、副腎皮質ステロイド、その他)、流通チャネル別(小売薬局、オンライン薬局、病院、その他)、地域別予測

【英語タイトル】Global Rheumatology Therapeutics Market Size study, by Disease Type (Rheumatoid Arthritis, Ankylosing Spondylitis, Osteoarthritis, Lupus, Gout, Others), by Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids, Others), by Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals, Others) and Regional Forecasts 2019-2026

Bizwit Research & Consultingが出版した調査資料(BZW9JN110)・商品コード:BZW9JN110
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2019年6月25日
・ページ数:約150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥426,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD5,550 ⇒換算¥599,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本資料は、リウマチ科治療法の世界市場について調べ、リウマチ科治療法の世界規模、市場動向、市場環境、疾病種類別(慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他)分析、薬種類別(非ステロイド性抗炎症薬(NSAID)、鎮痛剤、疾患修飾性抗リウマチ薬(DMARD)、副腎皮質ステロイド、その他)分析、流通チャネル別(小売薬局、オンライン薬局、病院、その他)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・リウマチ科治療法の世界市場概要
・リウマチ科治療法の世界市場環境
・リウマチ科治療法の世界市場動向
・リウマチ科治療法の世界市場規模
・リウマチ科治療法の世界市場規模:疾病種類別(慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他)
・リウマチ科治療法の世界市場規模:薬種類別(非ステロイド性抗炎症薬(NSAID)、鎮痛剤、疾患修飾性抗リウマチ薬(DMARD)、副腎皮質ステロイド、その他)
・リウマチ科治療法の世界市場規模:流通チャネル別(小売薬局、オンライン薬局、病院、その他)
・リウマチ科治療法の世界市場:地域別市場規模・分析
・リウマチ科治療法の北米市場規模・予測
・リウマチ科治療法のアメリカ市場規模・予測
・リウマチ科治療法のヨーロッパ市場規模・予測
・リウマチ科治療法のアジア市場規模・予測
・リウマチ科治療法の日本市場規模・予測
・リウマチ科治療法の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global Rheumatology Therapeutics Market valued approximately USD 44.38 billion in 2018 is anticipated to grow with a healthy growth rate of more than 2.73% over the forecast period 2019-2026. The Rheumatology Therapeutics Market is continuously growing in the global scenario at significant pace. Rheumatology therapeutics market consists of therapeutics used for the treatment of rheumatic disorders, which include rheumatoid arthritis, juvenile rheumatoid arthritis, spondylarthritis, systemic lupus erythematosus, and systemic sclerosis. It is also associated with pain disorders in joints, ligaments and muscles. Rising incidence of rheumatology diseases, rising geriatric population worldwide are the substantial driving factors of the market during the forecast period. Additionally, increasing awareness regarding diseases remittances therapies and growing healthcare expenditure are another factor that impelling the demand of rheumatology therapeutics across the globe. Moreover, technological advancements in pharmaceutical field and increasing investments in healthcare industry for research and development activities are the factors that likely to create numerous opportunity in the near future. However, high capital investment in drug development and presence of alternative such as biosimilar are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Rheumatology Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to rising geriatric population, growing healthcare expenditure and high adoption of biopharmaceuticals for the treatment in the region. Europe is estimated to grow at significant growth rate in the global Rheumatology Therapeutics market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to increasing prevalence of rheumatology diseases and rising number of patient population across the region.

The major market player included in this report are:
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
Amgen
Janssen Biotech
Novartis AG
Genentech
Takeda Pharmaceutical
Sanofi

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Rheumatoid Arthritis
Ankylosing Spondylitis
Osteoarthritis
Lupus
Gout
Others

By Drug Type:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Analgesics
Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Corticosteroids
Others
By Distribution Channel:

Retail Pharmacy
Online Pharmacy
Hospitals
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Rheumatology Therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Rheumatology Therapeutics Market, by Disease Type, 2016-2026 (USD Billion)
1.3.2. Rheumatology Therapeutics Market, by Drug Type, 2016-2026 (USD Billion)
1.3.3. Rheumatology Therapeutics Market, by Distribution Channel, 2016-2026 (USD Billion)
1.3.4. Rheumatology Therapeutics Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Rheumatology Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Rheumatology Therapeutics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Rheumatology Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Rheumatology Therapeutics Market, by Disease Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Rheumatology Therapeutics Market, Sub Segment Analysis
5.4.1. Rheumatoid Arthritis
5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.2. Ankylosing Spondylitis
5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.3. Osteoarthritis
5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.4. Lupus
5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.5. Gout
5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.6. Others
5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Rheumatology Therapeutics Market, by Drug Type
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Rheumatology Therapeutics Market, Sub Segment Analysis
6.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.2. Analgesics
6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.3. Disease Modifying Anti-Rheumatic Drugs (DMARDs)
6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.4. Corticosteroids
6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.5. Others
6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Rheumatology Therapeutics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Key Market Players
7.4. Rheumatology Therapeutics Market, Sub Segment Analysis
7.4.1. Retail Pharmacy
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. Online Pharmacy
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Hospitals
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Others
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Rheumatology Therapeutics Market, by Regional Analysis
8.1. Rheumatology Therapeutics Market, Regional Market Snapshot (2016-2026)
8.2. North America Rheumatology Therapeutics Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.4. Distribution Channels breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3. Europe Rheumatology Therapeutics Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3. Rest of Europe
8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4. Asia Rheumatology Therapeutics Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5. Latin America Rheumatology Therapeutics Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AbbVie
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Summary
9.3.1.4. Recent Developments
9.3.2. Pfizer
9.3.3. Bristol-Myers Squibb Company
9.3.4. Merck & Co.
9.3.5. Amgen
9.3.6. Janssen Biotech
9.3.7. Novartis AG
9.3.8. Genentech
9.3.9. Takeda Pharmaceutical
9.3.10. Sanofi
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF RHEUMATOLOGY THERAPEUTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF RHEUMATOLOGY THERAPEUTICS MARKET
TABLE 3. RHEUMATOLOGY THERAPEUTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISEASE TYPE 2016-2026 (USD BILLION)
TABLE 8. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DRUG TYPE 2016-2026 (USD BILLION)
TABLE 9. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
TABLE 10. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 61. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 62. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 64. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 66. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 67. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 68. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 69. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 70. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 71. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 72. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 73. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 74. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 75. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 76. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 77. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 78. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 79. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 80. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 81. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 82. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 83. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 84. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 85. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 86. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 87. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 88. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 89. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 90. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 91. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 92. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 93. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 94. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 95. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 96. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 97. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 98. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 99. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 100. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 101. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 102. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 103. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 104. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 105. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 106. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 107. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 108. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 109. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 110. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures
FIG 1. RHEUMATOLOGY THERAPEUTICS MARKET, RESEARCH METHODOLOGY
FIG 2. RHEUMATOLOGY THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. RHEUMATOLOGY THERAPEUTICS MARKET, KEY TRENDS 2017
FIG 5. RHEUMATOLOGY THERAPEUTICS MARKET, GROWTH PROSPECTS 2018-2026
FIG 6. RHEUMATOLOGY THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. RHEUMATOLOGY THERAPEUTICS MARKET, PEST ANALYSIS
FIG 8. RHEUMATOLOGY THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 19. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 20. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 21. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 22. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 23. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 24. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 25. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 26. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 27. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 28. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 29. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 30. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 31. RHEUMATOLOGY THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 32. NORTH AMERICA RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
FIG 33. EUROPE RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
FIG 34. ASIA PACIFIC RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
FIG 35. LATIN AMERICA RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
FIG 36. RHEUMATOLOGY THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)

★調査レポート[リウマチ科治療法の世界市場:疾病種類別(慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他)、薬種類別(非ステロイド性抗炎症薬(NSAID)、鎮痛剤、疾患修飾性抗リウマチ薬(DMARD)、副腎皮質ステロイド、その他)、流通チャネル別(小売薬局、オンライン薬局、病院、その他)、地域別予測] (コード:BZW9JN110)販売に関する免責事項を必ずご確認ください。
★調査レポート[リウマチ科治療法の世界市場:疾病種類別(慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他)、薬種類別(非ステロイド性抗炎症薬(NSAID)、鎮痛剤、疾患修飾性抗リウマチ薬(DMARD)、副腎皮質ステロイド、その他)、流通チャネル別(小売薬局、オンライン薬局、病院、その他)、地域別予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆